A novel approach to the synthesis of 3-methyl-1H-quinoxalin-2-ones has been described. These compounds were regioselectively prepared by starting from substituted phenylamines and alpha-chloropropionyl chloride through the efficient procedures of acylation, nitration, reduction, intramolecular alkylation, and oxidation.
A novel approach to the synthesis of 3-methyl-1H-quinoxalin-2-ones has been described. These compounds were regioselectively prepared by starting from substituted phenylamines and alpha-chloropropionyl chloride through the efficient procedures of acylation, nitration, reduction, intramolecular alkylation, and oxidation.
A series of novel N4-substituted thiophen-3-ylsulfonylquinoxalinone derivatives were designed and synthesized by variations of 2- and 5-position of the thiophene ring. All target molecules were tested for their anti-HIV-1 replication activities and compounds 1b and 1d were found to be the most potent inhibitors with an IC50 value at 10−8 mol L−1 level. The preliminary structure–activity relationships
通过改变噻吩环的2-和5-位,设计和合成了一系列新颖的N 4-取代的噻吩-3-基磺酰基喹喔啉酮衍生物。测试所有靶分子的抗HIV-1复制活性,发现化合物1b和1d是最有效的抑制剂,IC 50值为10 -8 mol L -1。根据CDOCKER预测的化合物1b的结合模式,分析了初步的结构活性关系。
Chinoxaline, Verfahren zu ihrer Herstellung und ihre Verwendung
申请人:HOECHST AKTIENGESELLSCHAFT
公开号:EP0509398A1
公开(公告)日:1992-10-21
Verbindungen der Formel I bzw. Ia
in der n und die Substituenten R¹ - R⁵ sowie X die genannte Bedeutung haben, weisen eine antivirale Wirksamkeit auf.
式 I 或 Ia 的化合物
其中 n 和取代基 R¹ - R⁵ 及 X 如上文所定义,具有抗病毒活性。
Synthesis and biological evaluation of N4-(hetero)arylsulfonylquinoxalinones as HIV-1 reverse transcriptase inhibitors
作者:Bailing Xu、Yan Sun、Ying Guo、Yingli Cao、Tao Yu
DOI:10.1016/j.bmc.2009.02.039
日期:2009.4
A series of novel N-4-(hetero) arylsulfonylquinoxalinone derivatives were prepared in a straight and efficient way. Of all the synthesized compounds, five compounds exhibited potent anti-HIV-1 replication activities with IC50 value at the level of 10(-7) mol/L. Preliminary structure-activity relationships were studied in details and that will shed light on the discovery of more potent non-nucleoside reverse-transcriptase inhibitors. (c) 2009 Elsevier Ltd. All rights reserved.
Kombinationspräparate, enthaltend ein Chinoxalin und ein Nukleosid